What is the story about?
What's Happening?
Plexāā, a medtech company, has introduced the BLOOM43 platform in the U.S. to coincide with Breast Cancer Awareness Month. This platform includes a wearable preconditioning medical device and a companion app designed to prepare patients for breast surgery. The BLOOM43 device is non-invasive and drug-free, intended for use at home before surgery. It employs Supraphysiological Preconditioning™, a technique that heats the skin to improve blood flow and release heat shock proteins, reducing the risk of skin necrosis and the need for follow-up surgeries. The companion app provides a comprehensive Prehab™ program, offering guidance on nutrition, physical health, and personalized rehabilitation plans.
Why It's Important?
The launch of the BLOOM43 platform addresses a significant gap in pre-surgical preparation, as many patients report feeling unprepared for breast surgery. By reducing complications such as skin necrosis and the need for additional surgeries, the device can potentially lower healthcare costs and improve patient outcomes. The platform empowers patients by providing them with tools to enhance their tissue health and overall readiness for surgery, which could lead to faster recovery times and reduced hospital stays. This innovation is particularly relevant for breast cancer patients undergoing reconstructive surgery, offering them a sense of control and preparedness.
What's Next?
The BLOOM43 device is now available for prescription by surgeons and can be accessed by hospitals, surgical centers, and clinics across the U.S. The companion app is available globally, allowing patients to engage with the Prehab™ program. As the platform gains traction, it may lead to broader adoption in surgical practices, potentially influencing pre-surgical protocols and patient care standards. The success of this launch could also encourage further innovations in pre-surgical preparation technologies.
AI Generated Content
Do you find this article useful?